Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Dexmedetomidine vs Midazolam in Orthopedic Cancer Surgeries
NCT06315634Phase 4Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, midazolam in postoperative pain, sponsored by National Cancer Institute. Started Mar 2021; status: completed.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06315634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06315634.